Inceptor Bio
Abe Maingi is Vice President of Business Development at Inceptor Bio. Prior to his current role, he spent seven years at Kineticos Life Sciences, an award-winning life sciences advisory firm, serving in roles of increasing responsibility. He is a partner in the Kineticos Disruptor Fund and serves as a board observer for Promaxo, a medical technology company that develops and commercializes customer-centric MRI systems and MRI-based technologies. He serves as Adjunct Faculty at University of North Carolina at Chapel Hill. Abe received his BA in Business Administration from Campbell University.
Inceptor Bio
Inceptor Bio’s vision is to improve the way difficult-to-cure cancers are treated, changing patients’ lives with breakthrough cell and gene therapies.